Company Announcement COPENHAGEN, Denmark; February 12, 2025 - Genmab A/S (Nasdaq: GMAB) announced today the publication of its Annual Report for 2024. Below is a summary of business progress in 2024 ...
Global net sales of EPKINLY/TEPKINLY were USD 281 million in 2024. Net product sales in the U.S. and Japan by Genmab were DKK 1,743 million in 2024 compared to DKK 421 million in 2023. EPKINLY was ...
Reuters Genmab increased operating profit more than expected in 2024 February 12, 2025 at 11:12 am EST Danish pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback